ABBV - AbbVie Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5101.33B
Enterprise Value 3133.58B
Trailing P/E 19.52
Forward P/E 17.26
PEG Ratio (5 yr expected) 11.47
Price/Sales (ttm)3.10
Price/Book (mrq)N/A
Enterprise Value/Revenue 34.09
Enterprise Value/EBITDA 69.58

Trading Information

Stock Price History

Beta (3Y Monthly) 0.77
52-Week Change 3-23.66%
S&P500 52-Week Change 36.70%
52 Week High 3100.23
52 Week Low 365.06
50-Day Moving Average 374.12
200-Day Moving Average 379.26

Share Statistics

Avg Vol (3 month) 39.12M
Avg Vol (10 day) 310.76M
Shares Outstanding 51.48B
Float 1.48B
% Held by Insiders 10.09%
% Held by Institutions 171.89%
Shares Short (Jun 28, 2019) 428.21M
Short Ratio (Jun 28, 2019) 42.45
Short % of Float (Jun 28, 2019) 42.16%
Short % of Shares Outstanding (Jun 28, 2019) 41.91%
Shares Short (prior month May 31, 2019) 419.6M

Dividends & Splits

Forward Annual Dividend Rate 44.28
Forward Annual Dividend Yield 46.27%
Trailing Annual Dividend Rate 34.06
Trailing Annual Dividend Yield 35.95%
5 Year Average Dividend Yield 43.45
Payout Ratio 4110.64%
Dividend Date 3Aug 15, 2019
Ex-Dividend Date 4Jul 12, 2019
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 16.42%
Operating Margin (ttm)37.13%

Management Effectiveness

Return on Assets (ttm)12.02%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)32.65B
Revenue Per Share (ttm)21.57
Quarterly Revenue Growth (yoy)-1.30%
Gross Profit (ttm)25.04B
EBITDA 13.95B
Net Income Avi to Common (ttm)5.33B
Diluted EPS (ttm)3.51
Quarterly Earnings Growth (yoy)-11.70%

Balance Sheet

Total Cash (mrq)5.23B
Total Cash Per Share (mrq)3.54
Total Debt (mrq)37.92B
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.04
Book Value Per Share (mrq)-5.29

Cash Flow Statement

Operating Cash Flow (ttm)13.8B
Levered Free Cash Flow (ttm)11.14B